Provis Biolabs Profile
Key Indicators
- Authorised Capital ₹ 6.50 M
as on 16-12-2024
- Paid Up Capital ₹ 6.25 M
as on 16-12-2024
- Company Age 5 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 17.00 Cr
as on 16-12-2024
- Satisfied Charges ₹ 1.53 Cr
as on 16-12-2024
- Revenue 40394.00%
(FY 2022)
- Profit 422.05%
(FY 2022)
- Ebitda 507.25%
(FY 2022)
- Net Worth 1109.53%
(FY 2022)
- Total Assets 98.63%
(FY 2022)
About Provis Biolabs
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.50 M and a paid-up capital of Rs 6.25 M.
The company currently has active open charges totaling ₹17.00 Cr. The company has closed loans amounting to ₹1.53 Cr, as per Ministry of Corporate Affairs (MCA) records.
Balareddy Bheemareddy and Nandini Narayanareddy serve as directors at the Company.
- CIN/LLPIN
U24290TG2019PTC135389
- Company No.
135389
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Sep 2019
- Date of AGM
19 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Provis Biolabs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Balareddy Bheemareddy  | Director | 12-Sep-2019 | Current |
| Nandini Narayanareddy | Director | 12-Sep-2019 | Current |
Financial Performance and Corporate Structure Insights of Provis Biolabs.
Provis Biolabs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 40394% increase. The company also saw a substantial improvement in profitability, with a 422.05% increase in profit. The company's net worth Soared by an impressive increase of 1109.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Provis Biolabs?
In 2022, Provis Biolabs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Provis Peptides Private LimitedActive 11 months 16 daysBalareddy Bheemareddy and Nandini Narayanareddy are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Sep 2023 | ₹17.00 Cr | Open |
Canara Bank Creation Date: 07 Jan 2021 | ₹1.53 Cr | Satisfied |
How Many Employees Work at Provis Biolabs?
Provis Biolabs has a workforce of 32 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Provis Biolabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Provis Biolabs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
